Chronic obstructive pulmonary disease is a condition caused by damage to the lungs that results in breathing difficulties.

COPD is a group of lung diseases that get worse over time. It prevents airflow to the lungs, causing breathing problems and ...

Chronic obstructive pulmonary disease (COPD) affects approximately 29 million people in the U.S. and is the fourth leading ...

Delhi’s air quality plunged to “hazardous” levels on Friday morning, with the city recording an overall Air Quality Index ...

As Delhi’s air quality plunges to hazardous levels, doctors are raising alarm over the severe impact of toxic air on children ...

Newswatch 16's Justin Gick spoke with a pulmonologist about the signs and symptoms of COPD and when to see a doctor.

"Chiesi drops COPD and asthma asset after Phase III miss" was originally created and published by Clinical Trials Arena, a ...

TAIPEI (Taiwan News) — Taiwan’s National Health Insurance Administration will enhance its pay-for-performance program for ...

Brensocatib, a DPP1 inhibitor, is the first FDA-approved therapy for non-cystic fibrosis bronchiectasis, showing significant clinical and structural benefits. The ASPEN trial demonstrated that ...

Brensocatib was associated with decreased exacerbation rates in patients with non-CF bronchiectasis, even in those with comorbid COPD.

I was diagnosed with COPD last year after struggling with multiple symptoms. I quit smoking over 10 years ago, but I’m ...

Regardless of blood eosinophil count threshold, adults with COPD and an eosinophilic phenotype experienced significantly fewer moderate/severe exacerbations in a year with mepolizumab vs. placebo, ...